Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
In the definitive SURMOUNT-5 head-to-head trial (NEJM 2025), tirzepatide produced ~20% weight loss vs
Fortunately, extensive research on these innovative medications is providing reassuring answers
Written By: Abhinay Wadekar, BPharm Reviewed By: Pharmacally Editorial Team Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) and member of WHO essential medicines list has revolutionized obesity management not only through substantial weight reduction but also through cardiovascular protection
Myth surrounding the FDA disapproval of hydroxychloroquine sulfate and chloroquine phosphate as drugs for coronavirus disease 2019
Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity
US$ 20.01
US$ 23.04
US$ 28.33
US$ 20.18
US$ 22.25
US$ 26.61
US$ 28.20
